Breaking News, Collaborations & Alliances

Bio Immunitas Enters Manufacturing Collaboration with GenScript ProBio

The partnership will fast-track Bio Immunitas' manufacturing and production from bench to bedside in an expedited timescale while maintaining regulatory milestones.

GenScript ProBio, a biologics contract development and manufacturing organization (CDMO) to the biopharmaceutical market, and Bio Immunitas, a UK pharmaceutical company with a novel, safe and efficacious human Recombinant Protein Platform (hRPP), announced a partnership for developing potential novel therapies for clinical use.  The long-term partnership will fast-track Bio Immunitas’ manufacturing and production from bench to bedside in an expedited timescale while maintaining regulato...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters